Cellular bioenergetics after erythropoietin therapy in chronic renal failure.

After erythropoietin (rHuEPO) therapy, patients with chronic renal failure (CRF) do not improve peak O2 uptake (VO2 peak) as much as expected from the rise in hemoglobin concentration ([Hb]). In a companion study, we explain this phenomenon by the concurrent effects of fall in muscle blood flow afte...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Clin Invest
Autores principales: Marrades, R M, Alonso, J, Roca, J, González de Suso, J M, Campistol, J M, Barberá, J A, Diaz, O, Torregrosa, J V, Masclans, J R, Rodríguez-Roisin, R, Wagner, P D
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Clinical Investigation 1996
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC507285/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8621800/
https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI118647
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares